See the DrugPatentWatch profile for Obinutuzumab
When does the obinutuzumab patent expire?
I don’t have enough provided information to state an exact obinutuzumab patent expiration date. Patent expiry depends on multiple filings (drug substance vs. formulation vs. method-of-use), country/jurisdiction, and whether there are extensions (for example, patent term adjustments or supplementary protection certificates).
Which jurisdiction matters for the expiry date?
The expiration date will differ by where you’re asking:
- US (FDA-related exclusivities vs. patents can differ from patent terms)
- EU/UK (often involves supplementary protection certificates)
- Other countries (where filing timelines and term calculations vary)
How can you find the exact expiry date for your country?
Look up:
- The specific patent family covering obinutuzumab (not just one “headline” patent number)
- The jurisdiction’s rules for term calculation and any extensions
- Whether any later patents cover line extensions (for example, new combinations or dosing regimens)
Is “patent expiry” the same as “market exclusivity” for obinutuzumab?
No. “Patent expiration” refers to the end of enforceable patent rights for specific claims, while “exclusivity” (regulatory or data exclusivity) can continue protection even after some patents expire, delaying generic/biosimilar approval or launch.
If you tell me your country, can you pin down the date?
Yes. Share the jurisdiction you care about (for example, US, UK, or EU country) and, if you have it, the reference patent number or product name details from your source. Then I can map the correct expiration timeline using the information you provide.
Sources
No sources were provided with the question, so I can’t cite any expiration date accurately.